Adenomyosis

Adenomyosis is a benign gynecologic condition in which endometrium-like tissue grows within the muscular wall of the uterus (myometrium). This makes the uterus enlarged, tender, and often “boggy” on examination. It is different from endometriosis, although the two conditions can coexist. In India, adenomyosis is commonly found in women in their 30s and 40s, but younger patients seeking fertility care may also be affected. Symptoms may range from mild to severe, and some women discover it only during infertility work-up or imaging done for heavy bleeding.

The exact cause of adenomyosis is not fully understood. Leading theories include invasion of endometrial tissue into the uterine muscle after repeated micro-injury to the uterine lining, especially after pregnancy, delivery, or uterine procedures. Hormonal factors, particularly estrogen sensitivity, are believed to play a major role, which is why symptoms often improve after menopause. There may also be associations with inflammation, abnormal uterine contractions, and altered immune responses. It is not caused by infection or poor hygiene, and in most patients it is not something they “did wrong.”

The most common symptoms are heavy menstrual bleeding, severe cramps, chronic pelvic pain, pain during intercourse, and a feeling of pressure or fullness in the lower abdomen. Some women have spotting between periods, clot passage, or anemia from recurrent blood loss. In fertility patients, symptoms may be subtle; a woman can have recurrent IVF failure or miscarriage without dramatic pain. Symptoms can overlap with fibroids and endometriosis, so proper evaluation is important. If periods are becoming heavier, more painful, or interfering with work and daily life, adenomyosis should be considered.

Adenomyosis may affect fertility by disturbing normal uterine contractions, reducing embryo implantation, and creating an inflammatory uterine environment that is less favorable for pregnancy. It may also coexist with endometriosis or fibroids, which further lowers fertility. In some patients, the uterus becomes enlarged, making implantation and early placental development harder. The effect is not the same for everyone: some women conceive naturally, while others need medical or IVF support. In fertility care, the key is to identify how extensive the disease is and whether the uterine cavity is affected before choosing the treatment plan.

Diagnosis usually starts with a detailed history and transvaginal ultrasound (TVS), which can show a bulky uterus, asymmetric wall thickening, myometrial cysts, and a heterogeneous appearance. MRI is more precise and is often used when ultrasound findings are unclear or when fertility planning depends on mapping the disease. Blood tests may be done to assess anemia if bleeding is heavy. In many Indian fertility clinics, a saline sonography or hysteroscopy may be added if the doctor needs to rule out cavity problems. Diagnosis is often clinical plus imaging; biopsy is not routinely required.

Treatment depends on symptoms, age, and fertility goals. For pain and heavy bleeding, doctors may use NSAIDs, tranexamic acid, or hormonal treatment such as progestins, LNG-IUS, or GnRH analogues. These can control symptoms but are not permanent cures. If pregnancy is desired, treatment is usually planned to optimize the uterus without delaying conception too long. Surgery is not the first choice for diffuse adenomyosis, but selected focal cases may benefit from adenomyomectomy in expert hands. If anemia is present, iron therapy is important. The best treatment is individualized after reviewing symptoms, scan findings, and the couple’s fertility timeline.

Adenomyosis can lower IVF success rates compared with women without the condition, mainly by reducing implantation and increasing miscarriage risk. In typical Indian fertility practice, success depends more on age, egg quality, embryo quality, severity of adenomyosis, and whether the uterine cavity is involved than on the diagnosis alone. For many patients, a structured protocol using down-regulation before embryo transfer, treating coexisting endometriosis, and transferring a single good-quality blastocyst can improve outcomes. As a realistic range, IVF pregnancy rates may be lower than standard age-matched expectations, but many patients still achieve pregnancy, especially with mild disease and good embryos. Exact success should be discussed case by case with your fertility specialist.

HomeIVF focuses on convenient, evidence-based fertility care with doctor-led planning, scan review, medication guidance, and coordinated testing in a patient-friendly way. For adenomyosis, this means assessing symptoms, checking uterine imaging, correcting anemia, and timing treatment around your fertility goals. Where suitable, HomeIVF can help you start with non-invasive evaluation at home-first convenience and then move to clinic-based procedures only when needed. This approach reduces delay, avoids unnecessary travel, and supports couples who need clear next steps for IVF, IUI, or medical management. The goal is a realistic, personalized plan rather than a one-size-fits-all protocol.

See a fertility specialist if you have heavy or painful periods for several months, unexplained infertility for 6-12 months, recurrent miscarriage, or repeated IVF failure. You should also seek evaluation sooner if you are over 35, have anemia, or have been told on ultrasound that the uterus is bulky or suggestive of adenomyosis. If you already have endometriosis, fibroids, or prior uterine surgery, fertility planning becomes even more important. Early consultation helps preserve time, especially for women who want pregnancy in the near future and need a clear plan for medication, imaging, and IVF timing.